+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

South Korea Dietary Supplements - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • PDF Icon

    Report

  • 110 Pages
  • September 2026
  • Region: South Korea
  • Mordor Intelligence
  • ID: 6287259
The South Korean dietary supplements market size was valued at USD 5.47 billion in 2025 to Rapid Population Aging And Increasing Demand For Healthy Longevity Solutions Rising Consumer Focus On Preventive Healthcare And Immune Health Management Rising Demand For Beauty-From-Within Supplements Expansion Of E-Commerce And Digital Health Platforms Improving Supplement Accessibility Growing Demand For Clinically Supported Functional Ingredients Increasing Popularity Of Personalized And Targeted NutritionUSD 5.72 billion in 2026, and is forecast to reach USD 7.38 billion by 2031 at a 5.24% CAGR over 2026-2031. This report is segmented by Product Type (Vitamins and Minerals, Fatty Acids, and More), Form (Tablets, Capsules and Softgels, and More), Consumer Group, Health Application (General Health and Wellness, Immunity Enhancement, and More), Distribution Channel (Supermarkets/Hypermarkets, Pharmacy/Drugstores, and More). The Market Forecasts are Provided in Terms of Value (USD).

South Korea Dietary Supplements Market Trends and Insights

Rapid Population Aging and Increasing Demand for Healthy Longevity Solutions

South Korea’s elderly population is expected to reach 10.51 million in 2025, accounting for 20.3% of the total population, while the old-age dependency ratio is projected to increase from 29.3 in 2025 to 47.7 in 2035, according to XINHUANET in September 2025. This demographic shift is moving the South Korean dietary supplements market beyond routine vitamin consumption toward longer-term support for bone, cognitive, sleep, and cardiovascular health. Older consumers in the South Korea dietary supplements market also tend to show stronger brand loyalty and pay closer attention to recognized functional claims. This behavior supports premium positioning for products that meet higher compliance and evidence standards. According to the Food Safety Korea database (MFDS), South Korea is expected to have approved 489 health functional food ingredients by December 2025, comprising 96 standardized ingredients and 393 individually recognized functional ingredients . This indicates the continued diversification of supplement ingredients. As a result, brands with recognized ingredients are better positioned to capture higher average spending from aging households. The long runway for this demand is reinforced by the projected rise in the dependency ratio through the next decade.

Rising Consumer Focus on Preventive Healthcare and Immune Health Management

According to Health and Market, November 2025, South Korean households are expected to record an 83.6% supplement purchase rate in 2025, marking the fifth consecutive year at the highest level in the consumer survey. This trend indicates a broader shift across adult age groups from treatment-led spending to prevention-led spending. The consumer base is no longer concentrated among seniors, as adults in their 20s to 40s increasingly adopt regular supplement routines. Consumers often purchase immunity products alongside gut-health and skin-health products, supporting larger basket sizes and multi-product brand portfolios. Probiotics indicate that the overlap between immunity and gut health already has scale, as stated in a Nutraingredients Article in June 2026.

Stringent Regulatory Approval and Compliance Requirements

South Korea’s Health Functional Food Act requires companies marketing products as health functional foods to demonstrate ingredient safety and efficacy before receiving recognition. Partial amendments slated for 2025 are expected to change standards for several functional ingredients and add new raw material categories, increasing the need for reformulation and relabeling. Further proposed amendments in late 2025 are expected to add pressure on management standards and ingredient specifications. These developments may slow product launch timelines for some brands, but they also help preserve the level of trust that Korean consumers expect from regulated claims. In the South Korea dietary supplements market, companies that plan early for clinical substantiation and label compliance are likely to be better positioned than companies that rely only on aggressive promotion.

Other drivers and restraints analyzed in the detailed report include:
  • Rising Demand for Beauty-From-Within Supplements
  • Expansion of E-Commerce and Digital Health Platforms Improving Supplement Accessibility
  • Intense Market Competition and Product Saturation

Segment Analysis

Vitamins and minerals account for 26.72% of the South Korean dietary supplements market size in 2025, making them the largest product type by current demand. In June 2026, South Korea's Ministry of Food and Drug Safety released production data indicating that vitamins and minerals are expected to remain the top-produced health functional food category for the second consecutive year in 2025. This performance aligns with the broad everyday use of multivitamins and minerals across age groups and income levels. The growth supports demand linked to cardiovascular, cognitive, and eye health, particularly among older consumers. As a result, the South Korea dietary supplements industry continues to derive current value from routine nutritional support, while adjacent functional categories strengthen their medical positioning.

Prebiotic and probiotic supplements are projected to expand at a CAGR of 7.13% within the South Korea dietary supplements market size through 2031, making them the fastest-growing product type. CJ Wellcare’s 2026 presentation on strain-specific prebiotic formulation, including data indicating up to 200-fold enhanced activity for CJLP133 in galactooligosaccharide environments, shows how growth is shifting toward clinically differentiated microbiome platforms. Collagen is also evolving into more sophisticated combinations with hyaluronic acid and antioxidants, aligning with premium consumer expectations. Vitamins and minerals are expected to lead exports followed by eicosapentaenoic acid and docosahexaenoic acid oils, indicating that domestic scale and export potential are reinforcing each other.

Capsules and softgels accounted for 33.42% of the market in 2025, maintaining their lead among delivery formats. These formats effectively support concentrated actives, such as omega-3 oils, fat-soluble vitamins, and probiotic blends, that require stronger protection. They also appeal to older consumers who prefer multiple functional ingredients in a single product rather than carrying multiple packs. Daewoong Pharmaceutical’s planned August 2025 launch of Haapssen, a 7-in-1 softgel using its X-GIS encapsulation technology, demonstrates how manufacturers are using the format to combine several actives in one unit. In the South Korea dietary supplements market, format leadership continues to favor products that simplify efficacy, dosage control, and routine adherence.

Gummies are projected to record a CAGR of 6.88% through 2031, making them the fastest-growing format in the South Korea dietary supplements market. Two user groups are driving this growth: children who need more palatable formats and adults aged 20 to 40 who value portability and habit formation. Chong Kun Dang’s April 2026 launch of Daily Wise, featuring seven gummy SKUs in seven-day pouches priced at KRW 1,000, demonstrates how low-ticket packs can expand access beyond premium channels. The launch also indicates that gummy manufacturing capabilities are becoming increasingly important for contract manufacturers and brand owners. Stable probiotic gummies and shelf-stable omega-3 gummies require more advanced technical execution than simple confectionery-style products. As a result, format competition in the South Korea dietary supplements market is increasingly linked to manufacturing capabilities rather than packaging appeal alone.

Complete Report Scope:

  • By Product Type
    • Vitamins and Minerals
    • Fatty Acids
    • Collagen
    • Prebiotic and Probiotic Supplements
    • Herbal Supplements
    • Others
  • By Form
    • Tablets
    • Capsules and Softgels
    • Powders
    • Gummies
    • Liquids
    • Others
  • By Consumer Group
    • Men
    • Women
    • Kids/Children
  • Health Application
    • General Health and Wellness
    • Immunity Enhancement
    • Skin, Hair, and Nail Care
    • Bone and Joint Health
    • Gastrointestinal and Gut Health
    • Energy and Weight Management
    • Other Health Applications
  • By Distribution Channel
    • Supermarkets/Hypermarkets
    • Pharmacy/Drugstores
    • Online Retail Channels
    • Other Distribution Channel

List of Companies Covered in this Report:

  • Korea Tobacco & Ginseng Corporation
  • Chong Kun Dang Holdings
  • Amway Corporation
  • Kolmar BNH Co., Ltd
  • Nu Skin Enterprises
  • Kwang Dong Pharmaceutical Co. Ltd
  • Cosmax Bio
  • SUHEUNG co., ltd.
  • Herbalife Nutrition Ltd.
  • Novarex
  • NPK Inc.
  • Bayer AG
  • Nestle S.A.
  • hy Co. Ltd.
  • Haleon Plc
  • CJ Wellcare
  • Daesang Wellife
  • Abbott Laboratories
  • Otsuka Holdings Co. Ltd

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET LANDSCAPE
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rapid Population Aging and Increasing Demand for Healthy Longevity Solutions
4.2.2 Rising Consumer Focus on Preventive Healthcare And Immune Health Management
4.2.3 Rising Demand for Beauty-From-Within Supplements
4.2.4 Expansion of E-Commerce and Digital Health Platforms Improving Supplement Accessibility
4.2.5 Growing Demand for Clinically Supported Functional Ingredients
4.2.6 Increasing Popularity of Personalized and Targeted Nutrition
4.3 Market Restraints
4.3.1 Stringent Regulatory Approval and Compliance Requirements
4.3.2 Intense Market Competition and Product Saturation
4.3.3 Consumer Skepticism Toward Supplement Health Claims
4.3.4 Premium product pricing limits Mass Adoption
4.4 Consumer Behaviour Analysis
4.5 Regulatory Outlook
4.6 Porter’s Five Forces
4.6.1 Threat of New Entrants
4.6.2 Bargaining Power of Buyers/Consumers
4.6.3 Bargaining Power of Suppliers
4.6.4 Threat of Substitute Products
4.6.5 Intensity of Competitive Rivalry
5 MARKET SIZE AND GROWTH FORECASTS (VALUE)
5.1 By Product Type
5.1.1 Vitamins and Minerals
5.1.2 Fatty Acids
5.1.3 Collagen
5.1.4 Prebiotic and Probiotic Supplements
5.1.5 Herbal Supplements
5.1.6 Others
5.2 By Form
5.2.1 Tablets
5.2.2 Capsules and Softgels
5.2.3 Powders
5.2.4 Gummies
5.2.5 Liquids
5.2.6 Others
5.3 By Consumer Group
5.3.1 Men
5.3.2 Women
5.3.3 Kids/Children
5.4 Health Application
5.4.1 General Health and Wellness
5.4.2 Immunity Enhancement
5.4.3 Skin, Hair, and Nail Care
5.4.4 Bone and Joint Health
5.4.5 Gastrointestinal and Gut Health
5.4.6 Energy and Weight Management
5.4.7 Other Health Applications
5.5 By Distribution Channel
5.5.1 Supermarkets/Hypermarkets
5.5.2 Pharmacy/Drugstores
5.5.3 Online Retail Channels
5.5.4 Other Distribution Channel
6 COMPETITIVE LANDSCAPE
6.1 Market Concentration
6.2 Strategic Moves
6.3 Market Share Analysis
6.4 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials (if available), Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
6.4.1 Korea Tobacco & Ginseng Corporation
6.4.2 Chong Kun Dang Holdings
6.4.3 Amway Corporation
6.4.4 Kolmar BNH Co., Ltd
6.4.5 Nu Skin Enterprises
6.4.6 Kwang Dong Pharmaceutical Co. Ltd
6.4.7 Cosmax Bio
6.4.8 SUHEUNG co., ltd.
6.4.9 Herbalife Nutrition Ltd.
6.4.10 Novarex
6.4.11 NPK Inc.
6.4.12 Bayer AG
6.4.13 Nestle S.A.
6.4.14 hy Co. Ltd.
6.4.15 Haleon Plc
6.4.16 CJ Wellcare
6.4.17 Daesang Wellife
6.4.18 Abbott Laboratories
6.4.19 Otsuka Holdings Co. Ltd
7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Korea Tobacco & Ginseng Corporation
  • Chong Kun Dang Holdings
  • Amway Corporation
  • Kolmar BNH Co., Ltd
  • Nu Skin Enterprises
  • Kwang Dong Pharmaceutical Co. Ltd
  • Cosmax Bio
  • SUHEUNG co., ltd.
  • Herbalife Nutrition Ltd.
  • Novarex
  • NPK Inc.
  • Bayer AG
  • Nestle S.A.
  • hy Co. Ltd.
  • Haleon Plc
  • CJ Wellcare
  • Daesang Wellife
  • Abbott Laboratories
  • Otsuka Holdings Co. Ltd